Know Cancer

or
forgot password

A Prospective Randomized Controlled Trial Comparing Billroth-I Reconstruction With Roux-en Y Reconstruction After Distal Gastrectomy for Gastric Cancer


Phase 3
20 Years
80 Years
Open (Enrolling)
Both
Gastric Cancer

Thank you

Trial Information

A Prospective Randomized Controlled Trial Comparing Billroth-I Reconstruction With Roux-en Y Reconstruction After Distal Gastrectomy for Gastric Cancer


The purpose of this study is to evaluate the quality of life (QOL) after Billroth-I
reconstruction (B-I) following distal gastrectomy, compared with Roux-en Y reconstruction
(R-Y) in patients with gastric cancer. There is no prospective randomized study of the two
operative procedures focusing on postoperative QOL. The investigators conducted a
prospective randomized trial on 120 patients who underwent distal gastrectomy comparing
Billroth-I reconstruction and Roux-en Y reconstruction.

The primary endpoint was the postoperative QOL. The secondary endpoints were the incidence
of postoperative complications, nutritional status, and the incidence of the remnant
gastritis and the reflux esophagitis. Patients were recruited into this study before
surgery, on the basis of whether distal gastrectomy was anticipated at Wakayama Medical
University Hospital(WMUH) for gastric cancer, and appropriate informed consent was obtained.
Exclusion criteria was 1) patients with severe complications which were possible to prolong
hospital stay, 2) patients with history of other organ malignancies, 3) patients who were
diagnosed inadequacy for this study by a physician, and 4) patients without an informed
consent.


Inclusion Criteria:



- Histologically confirmed adenocarcinoma of stomach

- Performance status: Eastern Cooperative Oncology Group (ECOG) 0-1

- Tumor located in the antrum or the angle or the lower body of stomach

- Appropriate informed consent was obtained.

Exclusion Criteria:

- Patients with severe complications which were possible to prolong hospital stay

- Patients with history of other organ malignancies

- Patients who were diagnosed inadequacy for this study by a physician

- Patients without an informed consent

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

the postoperative quality of life (QOL)

Outcome Time Frame:

3 years after operation

Safety Issue:

Yes

Principal Investigator

Masaki Nakamura, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Second Department of Surgery, Wakayama Medical University

Authority:

Japan: Ministry of Health, Labor and Welfare

Study ID:

WMU-GC03

NCT ID:

NCT01065688

Start Date:

January 2009

Completion Date:

December 2013

Related Keywords:

  • Gastric Cancer
  • distal gastrectomy
  • Billroth-I reconstruction
  • gastric cancer
  • QOL
  • Stomach Neoplasms

Name

Location